Literature DB >> 14586496

Effects of C1 esterase inhibitor administration on intestinal functional capillary density, leukocyte adherence and mesenteric plasma extravasation during experimental endotoxemia.

Christian Lehmann1,2, Jürgen Birnbaum3, Carsten Lührs3, Oskar Rückbeil3, Claudia Spies3, Sabine Ziemer4, Matthias Gründling5, Dragan Pavlovic5, Taras Usichenko5, Michael Wendt5, Wolfgang J Kox3.   

Abstract

OBJECTIVE: To determine the effects of C1 esterase inhibitor (C1-INH) administration on intestinal functional capillary density, leukocyte adherence, and mesenteric plasma extravasation during experimental endotoxemia. DESIGN AND
SETTING: Prospective, randomized, controlled animal study in the experimental laboratory of a university.
SUBJECTS: 42 male Wistar rats.
INTERVENTIONS: The animals were divided into three groups. One half of the animals of each group underwent studies of intestinal functional capillary density and leukocyte adherence on venular endothelium by intravital fluorescence microscopy. In the other half of the animals mesenteric plasma extravasation (FITC albumin) was determined by intravital fluorescence microscopy. Treatment groups received endotoxin infusion of 2.5 mg/kg per hour (group 2 and 3) and 100 U/kg b.w. C1-INH (group 3) during the 2 h of endotoxemia. MEASUREMENTS AND
RESULTS: Endotoxemia resulted in a significant decrease in mucosal functional capillary density (18.5% vs. controls), which was reduced by C1-INH administration (9.5%). Treatment with C1-INH also significantly attenuated intestinal leukocyte adherence in submucosal venules (35% vs. endotoxin group) and mesenteric plasma extravasation (44% vs. endotoxin group).
CONCLUSIONS: C1-INH administration diminishes endotoxin-induced changes in the intestinal microcirculation during experimental endotoxemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14586496     DOI: 10.1007/s00134-003-2042-2

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  30 in total

1.  C1-inhibitor attenuates human serum induced E-selectin expression of pig aortic endothelial cells.

Authors:  U O Sølvik; G Haraldsen; A E Fiane; E Boretti; E Thorsby; T E Mollnes
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

2.  Preparation of rat intestinal muscle and mucosa for quantitative microcirculatory studies.

Authors:  H G Bohlen; R W Gore
Journal:  Microvasc Res       Date:  1976-01       Impact factor: 3.514

3.  Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock.

Authors:  P M Jansen; B Eisele; I W de Jong; A Chang; U Delvos; F B Taylor; C E Hack
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

Review 4.  [Activation of plasma cascade systems in sepsis: role of C1 inhibitors].

Authors:  S Zeerleder; C Caliezi; M Redondo; J Devay; W A Wuillemin
Journal:  Schweiz Med Wochenschr       Date:  1999-10-02

5.  [The effect of C 1 esterase inhibitor on ischemia: reperfusion injury in the rat brain].

Authors:  N Akita; H Nakase; Y Kanemoto; T Kaido; T Nishioka; T Sakaki
Journal:  No To Shinkei       Date:  2001-07

Review 6.  Therapeutic inhibition of the complement system. Y2K update.

Authors:  S S Asghar; M C Pasch
Journal:  Front Biosci       Date:  2000-09-01

7.  The influence of C1-esterase inhibitor substitution on coagulation and cardiorespiratory parameters in an endotoxin-induced rabbit model of hypercoagulability.

Authors:  R U Scherer; R M Giebler; U Schmidt; D Paar; W J Kox
Journal:  Semin Thromb Hemost       Date:  1996       Impact factor: 4.180

8.  Interaction of prostaglandins, activated complement, and granulocytes in clinical sepsis and hypotension.

Authors:  G J Slotman; K W Burchard; J J Williams; A D'Arezzo; S A Yellin
Journal:  Surgery       Date:  1986-06       Impact factor: 3.982

9.  Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase.

Authors:  M S Brower; P C Harpel
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

10.  The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure.

Authors:  Z M Quezado; W D Hoffman; J A Winkelstein; I Yatsiv; C A Koev; L C Cork; R J Elin; P Q Eichacker; C Natanson
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Year in review in intensive care medicine, 2004. III. Outcome, ICU organisation, scoring, quality of life, ethics, psychological problems and communication in the ICU, immunity and hemodynamics during sepsis, pediatric and neonatal critical care, experimental studies.

Authors:  Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker; Benoit Vallet
Journal:  Intensive Care Med       Date:  2005-02-18       Impact factor: 17.440

Review 2.  C1 inhibitor: biologic activities that are independent of protease inhibition.

Authors:  Alvin E Davis; Shenghe Cai; Dongxu Liu
Journal:  Immunobiology       Date:  2006-12-11       Impact factor: 3.144

Review 3.  Biological activities of C1 inhibitor.

Authors:  Alvin E Davis; Pedro Mejia; Fengxin Lu
Journal:  Mol Immunol       Date:  2008-07-31       Impact factor: 4.407

4.  Peritoneal instillation of taurolidine or polihexanide modulates intestinal microcirculation in experimental endotoxemia.

Authors:  Helge Frieling; Kai-Steffen Lauer; Matthias Gründling; Taras Usichenko; Konrad Meissner; Theoni Kanellopoulou; Christian Lehmann; Michael Wendt; Dragan Pavlovic
Journal:  Int J Colorectal Dis       Date:  2006-11-21       Impact factor: 2.796

Review 5.  Bench-to-bedside review: the role of C1-esterase inhibitor in sepsis and other critical illnesses.

Authors:  Mervyn Singer; Annie M Jones
Journal:  Crit Care       Date:  2011-01-26       Impact factor: 9.097

6.  Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsis.

Authors:  Su Jin Jeong; Sang Hoon Han; Chang Oh Kim; Jun Yong Choi; June Myung Kim
Journal:  Crit Care       Date:  2013-05-27       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.